Alzheimer’s disease and molecules
Published 13 November 2007
Alzheimer's Society comment on research by Jason E. Gestwicki and colleagues at Howard Hughes Medical Institute and Stanford University Medical School in Stanford, CA.
'Amyloid protein is the core component of the plaques that develop in people's brains when they develop Alzheimer's disease. There are many exciting approaches currently being investigated to target the accumulation of amyloid, some of which are already being investigated in clinical trials.
The novel approach developed by Dr Gestwicki and colleagues is another example of the innovative methods that scientists are applying to tackle Alzheimer's disease and develop therapies that can prevent the accumulation of amyloid.'
Professor Clive Ballard
Director of research
